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At moment, radiation treatment remains a key component for
combined modality therapy (chemotherapy, CT, plus Radiother-
apy, RT) for Early Stage Hodgkin’s Disease (ESHD). The treatments
with the CT plus RT, although has behaved a reduction of the inci-
dence of relapse, have determined an increase of the acute toxic-
ity and the iatrogenic complications in the time. In consideration
of the high probability of cure of HD patients, the late sequelae
treatment-related have a remarkable clinical importance. Insofar,
if from a side the RT is the more effective single agent in the care
of the initial stages of the HD, from the other one can determine
an increase of the late iatrogenic toxicity, which are dependent on
the irradiated volume and radiation dose. However, the analysis is
based on the modern concept of cure, assessing risks and benefits
by evaluating the extent to which the treatment used was of real
therapeutic benefit and its effects on the quality of life of the
patients. The efficacy of radiation dose inferior to 36–40, in the
treatment of HD patients, has been shown by numerous studies.
Besides, the use of the involved field radiotherapy (IFRT), reducing
the irradiated fields, it is translated in a diminution of the late
toxicity to loaded of irradiated normal tissue. To this purpose,
the use of the positron emission tomography/computed tomogra-
phy (PET/CT) in the therapeutic planning, both in the staging and
in the determination of the volume target that in the evaluation
of the treatment, can determine a more appropriate delivery of
radiotherapy. Always in the optics of the reduction of the size of
the radiation field the PET/CT scan (pre-chemotherapy and
post-chemotherapy) it allows a greater accuracy in identifying
and contouring involved lymph nodes.
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